Primary Category:
Treatment Protocols
Disease Category:
Bladder, Genitourinary
Status:
Open
Phase III Randomized Adjuvant study of MK-3475 (Pembrolizumab) in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
NCT#03244384
Eligible for screening study DCP 001
